The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial

The objective of the present study was to assess the safety and efficacy of a therapeutic vaccine containing both HBsAg and HBcAg (NASVAC) in patients with chronic hepatitis B (CHB) three years after the end of treatment (EOT) as a follow-up of a phase III clinical trial. NASVAC was administered ten...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbar, Sheikh Mohammad Fazle, Al Mahtab, Mamun, Aguilar, Julio Cesar, Yoshida, Osamu, Khan, Sakirul, Penton, Eduardo, Gerardo, Guillen Nieto, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778341/
https://www.ncbi.nlm.nih.gov/pubmed/35062707
http://dx.doi.org/10.3390/vaccines10010045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778341/
https://www.ncbi.nlm.nih.gov/pubmed/35062707
http://dx.doi.org/10.3390/vaccines10010045

Ejemplares similares